Cian Healthcare Ltd.
| BSE: 542678 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE05BN01019 |
| BSE 00:00 | 22 Jun | 20.55 |
0 (0.00%) |
OPEN
16.00 |
HIGH
20.80 |
LOW
16.00 |
| NSE 05:30 | 01 Jan | Cian Healthcare Ltd |
| OPEN | 16.00 |
| PREVIOUS CLOSE | 20.55 |
| VOLUME | 14000 |
| 52-Week high | 33.80 |
| 52-Week low | 12.05 |
| P/E | |
| Mkt Cap.(Rs cr) | 51 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cian Healthcare Ltd. (CIANHEALTHCARE) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 518.45 | 4.65 | 0.91 | 3112.91 |
| Cipla | 942.10 | 26.90 | 2.94 | 2468.28 |
| Dr Reddy's Labs | 4379.80 | -20.10 | -0.46 | 2186.40 |
| Sun Pharma.Inds. | 826.55 | -4.25 | -0.51 | 2139.70 |
| Divi's Lab. | 3625.00 | -6.00 | -0.17 | 1954.72 |
| Glaxosmi. Pharma | 1499.60 | -0.10 | -0.01 | 1690.53 |
| Alkem Lab | 3013.50 | 12.45 | 0.41 | 1685.08 |
| Glenmark Pharma. | 392.20 | 5.20 | 1.34 | 1649.45 |
| Zydus Lifesci. | 361.00 | 4.25 | 1.19 | 1476.20 |
| Lupin | 622.95 | 11.55 | 1.89 | 1258.62 |
| Alembic Pharma | 729.20 | -1.75 | -0.24 | 1175.39 |
| Ipca Labs. | 908.70 | 16.75 | 1.88 | 1140.77 |
| Torrent Pharma. | 2907.20 | 47.80 | 1.67 | 1137.85 |
| Gland Pharma | 2659.80 | -42.05 | -1.56 | 997.01 |
| Sanofi India | 6360.00 | -76.40 | -1.19 | 944.40 |
| Laurus Labs | 464.35 | -0.15 | -0.03 | 750.09 |
| Abbott India | 18962.90 | 175.55 | 0.93 | 690.69 |
| Ajanta Pharma | 1250.95 | 16.15 | 1.31 | 675.64 |
| Wockhardt | 206.95 | -1.55 | -0.74 | 593.29 |
| Granules India | 277.00 | 4.20 | 1.54 | 552.78 |
Quick Links for Cian Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
